Cargando…
Treatment of hypertension by increasing impaired endothelial TRPV4‐KCa2.3 interaction
The currently available antihypertensive agents have undesirable adverse effects due to systemically altering target activity including receptors, channels, and enzymes. These effects, such as loss of potassium ions induced by diuretics, bronchospasm by beta‐blockers, constipation by Ca(2+) channel...
Autores principales: | He, Dongxu, Pan, Qiongxi, Chen, Zhen, Sun, Chunyuan, Zhang, Peng, Mao, Aiqin, Zhu, Yaodan, Li, Hongjuan, Lu, Chunxiao, Xie, Mingxu, Zhou, Yin, Shen, Daoming, Tang, Chunlei, Yang, Zhenyu, Jin, Jian, Yao, Xiaoqiang, Nilius, Bernd, Ma, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666316/ https://www.ncbi.nlm.nih.gov/pubmed/28899928 http://dx.doi.org/10.15252/emmm.201707725 |
Ejemplares similares
-
Pharmacological Targeting of KCa Channels to Improve Endothelial Function in the Spontaneously Hypertensive Rat
por: Khaddaj Mallat, Rayan, et al.
Publicado: (2019) -
Novel Phenolic Inhibitors of Small/Intermediate-Conductance Ca(2+)-Activated K(+) Channels, KCa3.1 and KCa2.3
por: Oliván-Viguera, Aida, et al.
Publicado: (2013) -
Parallel Selection on TRPV6 in Human Populations
por: Hughes, David A., et al.
Publicado: (2008) -
Mg(2+)-dependent Gating and Strong Inward Rectification of the Cation Channel TRPV6
por: Voets, Thomas, et al.
Publicado: (2003) -
Endothelial KCa channels: Novel targets to reduce atherosclerosis-driven vascular dysfunction
por: Vera, O. Daniel, et al.
Publicado: (2023)